Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025)

Elutia (ELUT) reported Net Equity Issued and Repurchased of $13.8 million for Q1 2025, up 359.87% sequentially from $3.0 million in Q3 2020.

Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Elutia (ELUT) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $13.8 million in Q1 2025.

  • For the quarter ending Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $13.8 million; the trailing twelve-month figure through Sep 2025 stood at $13.8 million (up 359.87% YoY), and the FY2020 full-year result was $3.4 million, up 50.66% from the prior year.
  • Net Equity Issued and Repurchased climbed to $13.8 million in Q1 2025, from $3.0 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $13.8 million in Q1 2025 to a low of $13.8 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 13.80 Mn
Mar 31, 2025 13.80 Mn
Sep 30, 2020 3.00 Mn
Sep 30, 2020 3.00 Mn
Mar 31, 2020 450,000.00
Mar 31, 2020 450,000.00